PI
ABBV icon

PEAK6 Investments’s AbbVie ABBV Stock Holding History

PEAK6 Investments’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$12.4M Buy
62,900
+17,900
+40% +$3.34M 0.03% 477
2024
Q2 		$7.72M Sell
45,000
-8,900
-17% -$1.47M 0.02% 613
2024
Q1 		$9.82M Buy
53,900
+43,500
+418% +$7.5M 0.03% 527
2023
Q4 		$1.61M Buy
10,400
+4,100
+65% +$598K 0.01% 1700
2023
Q3 		$939K Buy
6,300
+1,700
+37% +$250K ﹤0.01% 1895
2023
Q2 		$620K Sell
4,600
-56,900
-93% -$8.34M ﹤0.01% 2039
2023
Q1 		$9.8M Sell
61,500
-67,600
-52% -$10.3M 0.05% 396
2022
Q4 		$20.9M Buy
129,100
+115,100
+822% +$17.6M 0.12% 153
2022
Q3 		$1.88M Sell
14,000
-75,300
-84% -$10.8M 0.01% 1613
2022
Q2 		$13.6M Sell
89,300
-819,100
-90% -$125M 0.03% 663
2022
Q1 		$147M Sell
908,400
-1,106,600
-55% -$161M 0.31% 48
2021
Q4 		$273M Buy
2,015,000
+1,712,600
+566% +$202M 0.58% 23
2021
Q3 		$32.6M Buy
302,400
+139,400
+86% +$15.9M 0.07% 235
2021
Q2 		$18.4M Buy
163,000
+81,000
+99% +$9.12M 0.04% 396
2021
Q1 		$8.87M Sell
82,000
-107,660
-57% -$11.5M 0.02% 705
2020
Q4 		$20.3M Sell
189,660
-31,800
-14% -$3.06M 0.04% 399
2020
Q3 		$19.4M Sell
221,460
-36,100
-14% -$3.4M 0.05% 351
2020
Q2 		$25.3M Buy
257,560
+199,460
+343% +$17.6M 0.09% 205
2020
Q1 		$4.43M Buy
58,100
+9,100
+19% +$775K 0.03% 580
2019
Q4 		$4.34M Sell
49,000
-78,400
-62% -$6.51M 0.02% 686
2019
Q3 		$9.51M Buy
127,400
+91,400
+254% +$6.27M 0.06% 381
2019
Q2 		$2.62M Buy
36,000
+34,800
+2,900% +$2.74M 0.02% 1084
2019
Q1 		$97K Sell
1,200
-18,800
-94% -$1.54M ﹤0.01% 3243
2018
Q4 		$1.84M Sell
20,000
-15,000
-43% -$1.32M 0.01% 1289
2018
Q3 		$3.31M Buy
+35,000
New +$3.32M 0.01% 1062

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

PEAK6 Investments's ABBV Position: Q3 2024 in Review

PEAK6 Investments increased its AbbVie (ABBV) stake by 502% in Q3 2024, buying an estimated $2.22M and bringing the position to 14,248 shares worth $2.81M. The position accounts for 0.01% of the portfolio, ranked #1290.

PEAK6 Investments first reported a position in ABBV in Q3 2018 and has held it in 20 quarters since. The position peaked at $15.8M in Q2 2019. 3,499 funds tracked by Wall St. Rank hold ABBV as of Q3 2024.

  • PEAK6 Investments held 14,248 shares of AbbVie worth $2.81M as of Q3 2024.
  • PEAK6 Investments bought 11,883 AbbVie shares in Q3 2024, an estimated $2.22M.
  • AbbVie made up 0.01% of PEAK6 Investments's portfolio in Q3 2024, its #1290 holding.
  • PEAK6 Investments first reported a position in AbbVie in Q3 2018 and has held it in 20 quarters since.
  • PEAK6 Investments's AbbVie position peaked at $15.8M in Q2 2019.
  • 3,499 funds tracked by Wall St. Rank held AbbVie as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.